Balmer TV, Irvine D, Jones RS Comparison of carprofen and pethidine as postoperative analgesics in the cat. J Small Anim Pract. 1998; 39:158-64
Bergh MS, Budsbergh SC The Coxib NSAIDs: Potential Clinical and Pharmacologic Importance in Veterinary Medicine. J Vet Intern Med. 2005; 19:633-43
Botting R COX-1 and COX-3 inhibitors. Thromb Res. 2003; 110:269-72
Buvanendran A, Kroin J, Luk P Blood Brain Barrier penetration of oral rofecoxib, a potent and selective cyclo-oxygenase-2 inhibitor in dogs. Anesthesiology. 2002; 97
Chandrasekharan NV, Dai H, Roos KL COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA. 2002; 99:13926-31
Elia N, Lysakowski C, Tramer MR Does Multimodal Analgesia with Acetaminophen, Nonsteroidal Antiinflammatory Drugs, or Selective Cyclooxygenase-2 Inhibitors and Patient-controlled Analgesia Morphine Offer Advantages over Morphine Alone?. Anesthesiology. 2005; 103:1296-304
Flaherty D Understanding the mechanisms behind acute pain in dogs and cats. The Veterinary Nurse. 2013; 4:82-7
Frolich JC A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharm Science. 1997; 18:30-4
Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990; 265:16737-40
Grisneaux E, Pibarot P, Dupuis J, Blais D Comparison of ketoprofen and carprofen administered prior to orthopaedic surgery for control of postoperative pain in dogs. J Am Vet Med Assoc. 1999; 215:1105-110
Hanson PD, Brooks KC, Case J Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions. Vet Ther. 2006; 7:127-40
Khan SA, McLean MK Toxicology of Frequently Encountered Nonsteroidal Anti-Inflammatory Drugs in Dogs and Cats. Vet Clin North Am Small Anim Pract. 2012; 42:289-306
Kehlet H, Wilmore DW Multimodal strategies to improve surgical outcome. Am J Surg. 2002; 183:630-41
King JN, Gerring EL Antagonism of endotox-in-induced disruption of equine bowel motility by flunixin and phenylbutazone. Equine Vet J. 1989; 38-42
Knapp DW, Richardson RC, Chan TCK Piroxicam Therapy in 34 Dogs With Transitional Cell Carcinoma of the Urinary Bladder. J Vet Intern Med. 1994; 4:273-8
Königsson K, Gustafsson H, Kindahl H 15-Ketodihydro-PGF(2 alpha), progesterone and uterine involution in primiparous cows with induced retained placenta and post-partal endometritis treated with oxytetracycline and flunixin. Reprod Domest Anim. 2002; 37:43-51
Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 1991; 266:12866-72
Lascelles BDX, King S, Roe S, Marcellin-Little DJ, Jones S Expression and activity of COX-1 and 2 and 5-LOX in joint tissues from dogs with naturally occurring coxofemoral joint osteoarthritis. J Orthop Res. 2009; 27:1204-8
Liao LM, Vaughan TL, Corley DA Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology. 2012; 142:442-52
Mansa S, Palmér E, Grøndahl C, Lønaas L, Nyman G Long-term treatment with carprofen of 805 dogs with osteoarthritis. Vet Rec 160. 2007; 427-30
Marret E, Kurdi O, Zufferey P, Bonnet F Effects of Nonsteroidal Antiinflammatory Drugs on Patient-controlled Analgesia Morphine Side Effects. Anesthesiology. 2005; 102:1249-60
Mohammed SI, Bennett PF, Craig BA Effect of the cyclooxygenase inhibitor, piroxicam, on tumour response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Res. 2002; 62:356-8
Mohammed SI, Khan KNM, Sellers RS Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer. Prostaglandins Leukot Essent Fatty Acids. 2004; 70:479-83
Moreau M, Dupuis J, Bonneau NH, Desnoyers M Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dog with osteoarthritis. Vet Rec. 2003; 152:323-9
Muir WW, Woolf CJ Mechanism of pain and their therapeutic implications. J Am Vet Med Assoc. 2001; 219:1346-56
Parrott RF, Vellucci SV Comparison of the antipyretic actions of indomethacin and L-745, 337, a selective cyclooxygenase-2 inhibitor, in endotoxintreated prepubertal pigs. Gen Pharmacol. 1998; 30:65-9
Reid J, Nolan AM A comparison of the postoperative analgesic and sedative effects of flunixin and papaveretum in the dog. J Small Anim Pract. 1991; 32:603-8
Ritchie RM Optimizing postoperative pain management. Cleve Clin J Med. 2006; 73:S72-76
Schmassmann A, Peskar BM, Stettler C Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats. Br J Pharmacol. 1998; 123:795-804
Steinbach G, Lynch PM, Phillips RKS The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000; 26:1946-52
Stock JL, Shinjo K, Burkhardt J, Roach M, Taniguchi K, Ishikawa T, Kim HS, Flannery PJ, Coffman TM, Mc-Neish JD, Audoly LP The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J Clin Invest. 2001; 107:325-31
Vane JR Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs. Nat New Bio. 1971; 231:232-5
Wilson JE, Chandrasekharan NV, Westover KD, Kendra BE, Simmons DL Determination of expression of cyclooxygenase-1 and -2 isozymes in canine tissues and their differential sensitivity to nonsteroidal anti-inflammatory drugs. Am J Vet Res. 2004; 65:81-18
Zhang Y, Shaffer A, Portanova J, Seibert K, Isakson P Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyper-algesia and prostaglandin E2 production. J Pharmacol Exp Ther. 1997; 283:1069-75
